Organic compounds -- part of the class 532-570 series – Organic compounds – Oxygen containing
Patent
1998-10-07
1999-12-28
Geist, Gary
Organic compounds -- part of the class 532-570 series
Organic compounds
Oxygen containing
C07C 3506
Patent
active
060084170
ABSTRACT:
The invention is concerned with a multi-stage process for making an oxidative metabolite of the carotenoid lycopene, 2,6-cyclolycopene-1,5-diol having the formula ##STR1## In this process .alpha.-terpinyl acetate is oxidatively dihydroxylated to a cyclohexanediol (IV), the cyclohexanediol (IV) is oxidatively cleaved to a ketoaldehyde (V), the ketoaldehyde (V) is subjected to an intramolecular aldol condensation to give a cyclopentanol (VI), the cyclopentanol (VI) is silylated to its silylated derivative formylcylopentane (VII), the formylcyclopentane (VII) is subjected to a C.sub.3 -chain lengthening with acetone and simultaneously to a saponification for the cleavage of the acetyl group to give a cyclopentylbutenone (VIII), the cyclopentylbutenone (VIII) is reacted with vinyl magnesium bromide to give a pentadienol (IX), the pentadienol (IX) is converted with deprotection of the silylated hydroxy group into a phosphonium salt (X), this salt is subjected to a Wittig reaction with 2,7-dimethyl-2,4,6-octatriene-1,8-dial to give a tridecahexaenal (XII) and the tridecahexaenal (XII) is subjected to a Wittig reaction with a (3,7,11-trimethyl-dodeca-2,4,6,10-tetraenyl)triphenylphosphonium salt to give the desired 2,6-cyclolycopene-1,5-diol (II). A variant of this process, also in accordance with the invention, comprises converting the cyclopentylbutenone (VIII) into the phosphonium salt (X) via two alternative intermediates, namely a pentadienoic acid ester (XIV) and a different pentadienol (XV), into the same phosphonium salt (X). Moreover, the invention is concerned with the novel intermediates (V), (VI), (VII), (VIII), (IX), (X), (XII), (XIV) as well as (XV) and the individual process steps which lead to these novel intermediates. 2,6-cyclolycopene-1,5-diol is useful in the prevention of cancer growth in human cells.
REFERENCES:
patent: 3781314 (1973-12-01), Bollag
patent: 5166445 (1992-11-01), Meyer
J. Bertram, "The chemoprevention of cancer by dietary carotenoids: studies in mouse and human cells", Pure & Appl. Chem., vol. 66, No. 5, pp. 1025-1032 (1994).
N. Krinsky, "Carotenoids and Cancer: Basic Research Studies", Nat. Antioxid. Health Dis., pp. 239-261 (1994).
J. Bertram, "The chemoprevention of cancer by dietary carotenoids: studies in mouse and human cells", Oxid. Stress and Aging, pp. 221-235 (1995).
Narisawa et al., "Inhibitory effects of natural carotenoids, .alpha.-carotene, .beta.-carotene, lycopene and lutein, on colonic aberrant crypt foci formation in rats", Cancer Letters, vol. 107, pp. 137-142 (1996).
Bendich, "Recent Advances in Clinical Research Involving Carotenoids", Pure & Appl Chem., vol. 66, No. 5, pp. 1017-1024 (1994).
Levy et al., "Lycopene Is a More Potent Inhibitor of Human Cancer Cell Proliferation Than Either .alpha.-carotene or .beta.-carotene", Nutr. Cancer, vol. 24, pp. 257-266 (1995).
Giovannucci et al., "Intake of Carotenoids and Retinol in Relation to Risk of Prostate Cancer", J. of Natl. Cancer Inst., vol. 87, No. 23, pp. 1767-1776 (1995).
Khachik et al., "Lutein, Lycopene, and Their Oxidative Metabolites in Chemoprevention of Cancer", J. of Cell. Biochem., Suppl. 22, pp. 236-246 (1995).
Khachik et al., "Partial Synthesis of the Oxidative Metabolites of Lycopene Isolated from Human Serum", 11.sup.th International Symposium on Carotenoids, Leiden, The Netherlands, Aug. 18-23 1996.
Khachik et al., "Identification of Carotenoids and their Metabolites in Extracts from Human Plasma, Breastmilk, and Dissected Human Retina", 11.sup.th International Symposium on Carotenoids, Leiden, The Netherlands, Aug. 18-23 1996.
Khachik et al., "Metabolism of Dietary Carotenoids and their Potential Role in Prevention of Cancer and Age-related Macular Degeneration", Book of Abstracts, 213.sup.th ACS Nat. Meeting, San Francisco, California, USA, Apr. 13-14, 1997.
Lu et al., "A New Carotenoid, Hydrogen Peroxide Oxidation Products from Lycopene", Biosci. Biotech. Biochem., vol. 59, (11), pp. 2153-2155 (1995).
Hirata et al., "The Stereospecific Hydroxylation of Endocyclic Ethylenic Linkage in the Biotransformation of .alpha.-Terpinyl Acetate with Cultured Suspension Cells of Nicotiana Tabacum", Chem. Letters, pp. 671-674 (1982).
Hengartner et al., "Synthesis, Isolation, and NMR-Spectroscopic Characterization of Fourteen (Z)-Isomers of Lycopene and of Some Acetylenic Didehydro- and Tetradehydrolycopenes", Helv. Chim. Acta, vol. 75, pp. 1848-1865 (1992).
Weber et al., "An Improved Procedure for the KMnO.sub.4 Oxidation of Olefins to Cis-1,2-Glycols by use of Phase Transfer Catalysis", Tetr. Letters, No. 48, pp. 4907-4908 (1972).
Milas et al., "The Hydroxylation of the Double Bond", J.A.C.S., vol. 58, pp. 1302-1304 (1936).
Koyama et al., "Synthesis of (-)-Ambrox from L-Abietic Acid", Tetr. Letters, vol. 28, No. 25, pp. 2863-2866 (1987).
Newhall, "Derivatives of (+)-Limonene.I. Esters of trans-p-Menthane-1,2-diol", J. Org. Chem. vol. 23, pp. 1274-1276 (1958).
Viski et al., "A Novel Procedure for the Cleavage of Olefin Derivatives to Aldehydes Using Potassium Permanganate", J. Org. Chem., vol. 51, pp. 3213-3214 (1986).
Meinwald et al., "Synthesis and Stereochemistry of Chrysomelidial and Plagiolactone", J.A.C.S., vol. 100, pp. 1883-1886 (Mar. 15, 1978).
Sakai et al., "Revisions of the Absolute Configurations of C-8 Methyl Groups in Dehydroiridodiol, Neonepetalactone , and Matatabiether from Actinidia Polygama MIQ", Tetrahedron Letters, vol. 36, pp. 3115-3119 (1980).
Wolf et al., n-Butyl Glyoxylate, Organic Synthesis, vol. IV, pp. 124-125 (1963).
Merrer et al., "Total Synthesis of Leukotriene (+)-LTB.sub.4 from D-Mannitol", Tetrahedron Letters, vol. 27, No. 35, pp. 4161-4164 (1986).
Wolinsky et al., "Synthesis of 4-(2-Methyl-5-isopropenyl-1-cyclopenten-1-yl)butan-2-one", J. Org. Chem., vol. 29, pp. 3740-3742 (1964).
Greene et al., Protective Groups in Organic Synthesis, 2.sup.nd Edition, John Wiley & Sons, Inc., New York, pp. 68-83.
Traber et al., "Synthesis of (all-E,2R,2'R)-Oscillol", Helvetica Chimica Acta, vol. 79, pp. 499-506 (1996).
Kienzle et al., "Die Synthese von Actinioerthrol, Violerythrin und anderen 2,2'-Dinor-carotenoiden", Helvetica Chimica Acta, vol. 61, Nr. 18, pp. 242-249 (1978).
Haag et al., "Isozeaxanthins: Chiralitat und enantioselektive Synthese von (4R,4'R)-Isozeaxanthin ((+)-(4R,4'R)-.beta.,.beta.-Carotin-4,4'-diol)", Helvetica Chimica Acta, vol. 65, Nr. 177, pp. 1795-1803 (1982).
Buschor et al., "Synthese der (3S,4R,3'S,4'R)-und (3S,4S,3'S,4'S)-Crustaxanthine sowie weiterer verbindungen mit 3,4-Dihydroxy-.beta.-Endgruppen", Helvetica Chimica Acta, vol. 73, pp. 1002-1021 (1990).
Houben-Weyl, "Ketone II", Methoden der org. Chem., vol. 7, Part 2B, pp. 1448-1487.
Organikum, Organisch-chemishces Grundpraktikum, 17.sup.th Edition (VEB Deutscher Verlag der Wissenschaften, Berlin), p. 261 (1988).
CA: 124:87418 by Lu in Biosci., Biotechnol, Biochem 59(11) pp. 2153-5, 1995 .
Pfander Hanspeter
Traber Bruno
Ebel Eileen M.
Geist Gary
Johnston George W.
Roche Vitamins Inc.
Tramaloni Dennis P.
LandOfFree
Process for making metabolites of lycopene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for making metabolites of lycopene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for making metabolites of lycopene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2383557